A stricter control of low-density lipoprotein is necessary for thrombosis reduction in “lower thrombosis risk” patients with atrial fibrillation: a multicenter retrospective cohort study-Reference-Cited by-同舟云学术

A stricter control of low-density lipoprotein is necessary for thrombosis reduction in “lower thrombosis risk” patients with atrial fibrillation: a multicenter retrospective cohort study

Published:2020-04-13 Issue:4 Volume:50 Page:849-857
ISSN:0929-5305
Container-title:Journal of Thrombosis and Thrombolysis
language:en
Short-container-title:J Thromb Thrombolysis

Author:

Liu Weizhuo,Xiong Nanqing,Xie Kun,Wu Bangwei,Qi Zhiyong,Zhou Peng,Gao Wen,Bao Liwen,Gao Xiufang,Qiu Zhaohui,Gong Hui,He Guibin,Cao Bin,Shi Haiming,Luo Xinping,Li Jian^ORCID

Funder

Natural Science Foundation of Shanghai

Huashan Hospital Fudan University

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Hematology

Link

https://link.springer.com/content/pdf/10.1007/s11239-020-02110-x.pdf

Reference22 articles.

1. Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH Jr, Zheng ZJ, Forouzanfar MH, Naghavi M, Mensah GA, Ezzati M, Murray CJ (2014) Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation 129:837–847

2. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P, ESC Scientific Document Group (2016) ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016(37):2893–2962